Glaucoma News and Research RSS Feed - Glaucoma News and Research

While there are many causes of glaucoma, most cases are associated with increased intraocular pressure. Loss of vision is usually characterized by a gradual reduction in peripheral vision, which can lead to a tunnel vision effect. Glaucoma affects approximately 100 million people globally and is one of the leading causes of blindness in the world today. An estimated three million Americans have this sight-threatening disease. Because it is painless and advances gradually, many people who have glaucoma or elevated IOP have not been diagnosed. If detected and treated early, vision can usually be preserved.
Researchers explore cause for increasing use of cannabis among older Americans

Researchers explore cause for increasing use of cannabis among older Americans

The U.S. Substance Abuse and Mental Health Services Administration has reported that cannabis use by persons over age 50 has outpaced recent growth observed across all other age groups. [More]
NIH highlights key tips and facts about glaucoma

NIH highlights key tips and facts about glaucoma

January is Glaucoma Awareness Month. The National Eye Institute, part of NIH, is highlighting key facts about this blinding disease, important tips for prevention and treatment, and research updates you may not know about. [More]
Study shows new role of zinc in optic nerve injury

Study shows new role of zinc in optic nerve injury

For more than two decades, researchers have tried to regenerate the injured optic nerve using different growth factors and/or agents that overcome natural growth inhibition. [More]
January is Glaucoma Awareness Month - GRF shares information about sight-stealing disease

January is Glaucoma Awareness Month - GRF shares information about sight-stealing disease

January is National Glaucoma Awareness Month, an important time to spread the word about this sight-stealing disease. [More]
New imaging technique could revolutionize assessment of eye health and disease

New imaging technique could revolutionize assessment of eye health and disease

Researchers at the University of Rochester Medical Center have developed a new imaging technique that could revolutionize how eye health and disease are assessed. [More]
Sight Sciences receives Health Canada approval for TRAB 360 Trabeculotomy System

Sight Sciences receives Health Canada approval for TRAB 360 Trabeculotomy System

Sight Sciences, Inc., a venture-backed, commercial-stage ophthalmic medical device company announced today that it has received Health Canada approval for the TRAB 360 Trabeculotomy System. [More]
Researchers use worms as model system to study how gut microbiome influences disease

Researchers use worms as model system to study how gut microbiome influences disease

The billions of microorganisms living within the human digestive tract appear to play a significant role in health and disease, notably metabolic syndrome, autoimmune disorders and diabetes - but how these organisms do so is not well understood. [More]
New glasses may help expand sight of person with limited peripheral vision

New glasses may help expand sight of person with limited peripheral vision

Vision scientists may have discovered how to reduce pedestrian collisions in crowded and chaotic open space environments like bus terminals, shopping malls and city plazas involving individuals with partial blindness. [More]
New book provides insights into latest treatments for partial blindness

New book provides insights into latest treatments for partial blindness

In Restoring Low Vision, renowned neuroscientist Bernhard Sabel explains cutting-edge science in language that patients can easily understand and provides a comprehensive look at the latest treatments for partial blindness. [More]
New contact lens therapy effective in slowing progression of juvenile-onset myopia, study shows

New contact lens therapy effective in slowing progression of juvenile-onset myopia, study shows

A groundbreaking contact lens therapy has potential to impact the fast-growing issue of myopia (nearsightedness) among children, based on research presented at the American Academy of Optometry's 95th Annual Meeting. [More]
Bone density could be one of early indicators of brain degeneration in Alzheimer's disease

Bone density could be one of early indicators of brain degeneration in Alzheimer's disease

Researchers at NEOMED have just identified a major connection between areas of the brainstem - the ancient area that controls mood, sleep and metabolism - and detrimental changes to bone in a preclinical model of Alzheimer's disease (AD). [More]
Zika virus can cause glaucoma in infants, report reveals

Zika virus can cause glaucoma in infants, report reveals

A team of researchers in Brazil and at the Yale School of Public Health has published the first report demonstrating that the Zika virus can cause glaucoma in infants who were exposed to the virus during gestation. [More]
Allergan gets FDA approval for new XEN Glaucoma Treatment System

Allergan gets FDA approval for new XEN Glaucoma Treatment System

Allergan plc announced today the U.S. Food and Drug Administration has cleared the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) for use in the U.S. [More]
Noninvasive biomedical imaging technology uses light to map the brain

Noninvasive biomedical imaging technology uses light to map the brain

Scientific progress has provided a solid understanding of the anatomy of the brain. However, there is still no reliable way to examine neuron to neuron communication, as it happens--a key to understanding the correlation between brain structure and brain function. [More]
Researchers compare effectiveness of two treatments for glaucoma

Researchers compare effectiveness of two treatments for glaucoma

Researchers at Queen's University Belfast together with University of St Andrews and Aberdeen have found that the procedure used to remove cataracts is more successful than current standard treatments with laser in treating Primary Angle-Closure Glaucoma - a leading cause of irreversible blindness worldwide. [More]
Education has greater influence on development of myopia than cognitive ability, study finds

Education has greater influence on development of myopia than cognitive ability, study finds

Environmental factors such as education and leisure activities have a greater influence on the development of short-sightedness or myopia than the ability to think logically and solve problems. [More]
CannaCure Florida offers medical cannabis educational conference following legalization of marijuana

CannaCure Florida offers medical cannabis educational conference following legalization of marijuana

CannaCure Florida is proudly offering the most comprehensive medical cannabis educational conference following passage of Florida Amendment 2 legalizing medical marijuana. [More]
Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Second Sight Medical Products, Inc. (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing the initial human proof of concept for the ongoing development of the Company's Orion™ I Visual Cortical Prosthesis (Orion I). [More]
New partnership-funded research could lead to better treatment for birdshot

New partnership-funded research could lead to better treatment for birdshot

Birdshot uveitis is a rare autoimmune disorder that has the potential to blind. It’s notoriously hard to treat. [More]
Novel methods may be effective in treating people with presbyopia

Novel methods may be effective in treating people with presbyopia

Researchers are testing cutting-edge treatments for people who want to see up close without reading glasses and finding promising results, according to studies presented this week at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology. [More]
Advertisement
Advertisement